Literature DB >> 5779733

Control of pseudomonas infection in burns by silver sulfadiazine.

C L Fox, B W Rappole, W Stanford.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5779733

Source DB:  PubMed          Journal:  Surg Gynecol Obstet        ISSN: 0039-6087


× No keyword cloud information.
  24 in total

1.  New advances in the topical treatment of burns.

Authors:  R L Greenberg
Journal:  Calif Med       Date:  1970-11

Review 2.  [Effector molecules of the innate immune system for treatment of wound infections].

Authors:  L Steinsträsser; S Langer; M Lehnhardt; H U Steinau
Journal:  Chirurg       Date:  2007-04       Impact factor: 0.955

3.  In vitro penetration of topical antiseptics through eschar of burn patients.

Authors:  M M Stefanides; C E Copeland; S D Kominos; R B Yee
Journal:  Ann Surg       Date:  1976-04       Impact factor: 12.969

4.  Advances in the clinical care of burned patients.

Authors:  P W Curreri; J A Marvin
Journal:  West J Med       Date:  1975-10

5.  Chitosan composite films. Biomedical applications.

Authors:  Galo Cárdenas; Paola Anaya; Carlos von Plessing; Carlos Rojas; Jackeline Sepúlveda
Journal:  J Mater Sci Mater Med       Date:  2007-12-29       Impact factor: 3.896

6.  Mechanism of resistance to silver ions in Klebsiella pneumoniae.

Authors:  P Kaur; D V Vadehra
Journal:  Antimicrob Agents Chemother       Date:  1986-01       Impact factor: 5.191

7.  Control of infection with gram-negative bacteria in patients at special risk.

Authors:  E J Lowbury
Journal:  Proc R Soc Med       Date:  1971-09

8.  Specificity of deoxyribonucleic Acid intercalating compounds in the control of phenylalanine ammonia lyase and pisatin levels.

Authors:  L A Hadwiger; M E Schwochau
Journal:  Plant Physiol       Date:  1971-03       Impact factor: 8.340

9.  Drug resistance in relation to use of silver sulphadiazine cream in a burns unit.

Authors:  K Bridges; E J Lowbury
Journal:  J Clin Pathol       Date:  1977-02       Impact factor: 3.411

10.  Silver sulfadiazine: interaction with isolated deoxyribonucleic acid.

Authors:  H S Rosenkranz; S Rosenkranz
Journal:  Antimicrob Agents Chemother       Date:  1972-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.